Hypertensive disorders complicating pregnancy (HDCP) are common pregnancy-related disorders. In this study, we aimed to study the clinical value of flow-mediated dilation (FMD) in HDCP and its association with endothelial dysfunction and HDCP-related factors. 160 HDCP patients and 120 healthy pregnancies were enrolled in the study. The expressions of endothelial function markers and FMD were determined. In addition, their correlations in HDCP patients were also analyzed using Pearson’s correlation analysis. FMD value decreased gradually from normal pregnancy to severe PE. The levels of plasma nitric oxidase (NO) were significantly lower in the HDCP group than those in the control group, while the levels of plasma endothelin-1 (ET-1) were increased dramatically in the HDCP group. Moreover, the levels of placental growth factor (PLGF) in HDCP women were significantly lower, while the soluble FMS-like tyrosine kinase 1 (sFLt-1) levels were markedly higher than those in control. In addition, the FMD value was correlated with the levels of plasma NO, ET-1, PLGF and sFlt1. It was also found that lower levels of FMD correspond to endothelial dysfunction and abnormal concentrations of PLGF and sFlt-1. The FMD value was associated with endothelial function indicators and could be a strong and non-invasive measure to predict HDCP. The association between the FMD values and endothelial function indicators in HDCP could be helpful for the prediction of pregnant hypertension more accurately.
SullivanSD, UmansJG, RatnerR, Hypertension complicating diabetic pregnancies: Pathophysiology, management, and controversies, Journal of Clinical Hypertension (Greenwich, Conn)2011;13(4):275–284.
2.
XiaoZ, WangY, ThaiPN, LiX, LuX, PuJ. Mechanisms linking hyperglycemia in pregnancy to the offspring cardiovascular system dysfunction, STE Medicine2021;2(7):e91.
3.
ZengY, LiM, ChenY, WangS, Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy, International Journal of Clinical and Experimental Pathology2015;8(11):15275–15279.
4.
HeilmannL, SiekmannU, Schmid-SchonbeinH, LudwigH, Hemoconcentration and pre-eclampsia, Arch Gynecol1981;231(1):7–21.
5.
SibaiBM, StellaCL, Diagnosis and management of atypical preeclampsia-eclampsia, American Journal of Obstetrics and Gynecology2009;200(5):481e481–e487.
Hypertension in pregnancyReport of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy, Obstetrics and Gynecology2013;122(5):1122–1131.
8.
Gynecologists ACoOaHypertension in pregnancy, Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstetrics and Gynecology2013;122(5):1122–1131.
9.
JungF, KolepkeW, SpitzerS, KiesewetterH, RuprechtKW, BachR, et al., Primary and secondary microcirculatory disorders in essential hypertension, Clin Investig1993;71(2):132–138.
10.
WolfS, ArendO, SchulteK, IttelTH, ReimM, Quantification of retinal capillary density and flow velocity in patients with essential hypertension, Hypertension1994;23(4):464–467.
11.
JungF, PindurG, OhlmannP, SpitzerG, SternitzkyR, FrankeRP, et al., Microcirculation in hypertensive patients, Biorheology2013;50(5-6):241–255.
12.
LaurentS, Agabiti-RoseiC, BrunoRM, RizzoniD. Microcirculation and macrocirculation in hypertension: A dangerous cross-link? Hypertension2022;79(3):479–490.
13.
OhlmannP, JungF, MrowietzC, AltT, AltS, SchmidtWPeripheral microcirculation during pregnancy and in women with pregnancy induced hypertension, Clin Hemorheol Microcirc2001;24(3):183–191.
14.
PellandA, GeorgeRB, LehmannC, CoolenJ, Sidestream dark field imaging of the microcirculation to assess preeclampsia microvascular dysfunction, J Clin Med Res2018;10(5):391–395.
Berenji ArdestaniS, EftedalI, PedersenM, JeppesenPB, NorregaardR, MatchkovVV, Endothelial dysfunction in small arteries and early signs of atherosclerosis in ApoE knockout rats, Scientific Reports2020;10(1):15296.
17.
Kruger-GengeA, BlockiA, FrankeRP, JungF, Vascular endothelial cell biology: An update, Int J Mol Sci2019;20(18).
18.
CharreauB, Advances in endothelial cell biology: From knowledge to control2022;23(12):6403.
19.
MalhotraAS, GoelP, ChaudharyA, KochharS, KaurG, BhagatA, Serial profile of flow-mediated dilatation in primigravida for prediction of preeclampsia and gestational hypertension, Hypertension in Pregnancy.2018;37(4):212–219.
20.
Lopes van BalenVA, van GansewinkelTAG, de HaasS, van KuijkSMJ, van DrongelenJ, Ghossein-DohaC, et al., Physiological adaptation of endothelial function to pregnancy: Systematic review and meta-analysis, Ultrasound Obstet Gynecol2017;50(6):697–708.
21.
Adu-BonsaffohK, AntwiDA, GyanB, ObedSA, Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women, BMC Physiology2017;17(1):5.
22.
VieiraMC, da Cunha FilhoEV, PaulaLG, HentschkeMR, Poli-de-FigueiredoCE, Pinheiro da CostaBE, Flow-mediated dilatation of brachial artery as marker of preeclampsia morbidity, International Journal of Cardiology2013;168(4):4424–4425.
23.
GallinelliA, NicoliA, CapodannoF, ValliB, FacchinettiF, La SalaGB, Nitric oxide as an early marker of human embryo metabolic cleavage in ART using fresh or thawed oocytes, European Journal of Obstetrics, Gynecology, and Reproductive Biology2009;142(1):48–52.
24.
CorrettiMC, AndersonTJ, BenjaminEJ, CelermajerD, CharbonneauF, CreagerMA, et al., Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force, Journal of the American College of Cardiology2002;39(2):257–265.
25.
MaynardSE, MinJY, MerchanJ, LimKH, LiJ, MondalS, et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, Journal of Clinical Investigation2003;111(5):649–658.
26.
LivingstonJC, ChinR, HaddadB, McKinneyET, AhokasR, SibaiBM, Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia, American Journal of Obstetrics and Gynecology2000;183(6):1554–1557.
27.
DuleyL, The global impact of pre-eclampsia and eclampsia, Seminars in Perinatology2009;33(3):130–137.
28.
HanC, XianZ, ZouY, LiaoZ, YangR, ZouC, et al., Flow-mediated dilation can be used to predict incident hypertension in patients with hyperuricemia, Archives of Medical Science2019;15(2):343–349.
29.
BucciT, ParenteR, De FeoG, CardamoneC, TriggianiM, Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis, J Allergy Clin Immunol2019;144(4):1106–1111.
30.
HaynesWG, NoonJP, WalkerBR, WebbDJ, Inhibition of nitric oxide synthesis increases blood pressure in healthy humans, Journal of Hypertension1993;11(12):1375–1380.
31.
YallampalliC, GarfieldRE, Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia, American Journal of Obstetrics and Gynecology1993;169(5):1316–1320.
32.
NishikawaS, MiyamotoA, YamamotoH, OhshikaH, KudoR, The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia, Life Sciences2000;67(12):1447–1454.
33.
Seremak-MrozikiewiczA, BarlikM, PerlikM, KurzawinskaG, DrewsK, Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia, Ginekologia Polska2011;82(5):363–370.
34.
MasakiT, Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol. 1995;35235-255.
35.
ChauK, HennessyA, MakrisA, Placental growth factor and pre-eclampsia, Journal of Human Hypertension. 2017;31(12):782–786.
36.
RatsepMT, CarmelietP, AdamsMA, CroyBA, Impact of placental growth factor deficiency on early mouse implant site angiogenesis, Placenta2014;35(9):772–775.
37.
ZeislerH, LlurbaE, ChantraineF, VatishM, StaffAC, SennstromM, et al., Predictive value of the sFlt-PlGF ratio in women with suspected preeclampsia, New England Journal of Medicine2016;374(1):13–22.
